BioChem Pharma Will Adopt Governance By The Canada Business Corporations Act As Of 1998.LAVAL, QUEBEC, Canada--(BUSINESS WIRE)--Dec. 23, 1997--BioChem Pharma Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BCHE BChE abbr. Bachelor of Chemical Engineering ; Montreal Exchange and Toronto Stock Exchange Toronto Stock Exchange (TSE) Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options. : BCH BCH Beach BCH Banco Central de Honduras BCH Boot Console Handler BCH Boulder Community Hospital (Boulder, CO, USA) BCH Broadcast Channel BCH Belfast City Hospital BCH Banco Central-Hispano ) announced today that it will complete on December 31, 1997, its previously announced legal reorganization. As approved by the shareholders at BioChem Pharma's Annual Shareholders' Meeting held in May 1997, BioChem Pharma Inc. and its wholly-owned subsidiary, BioChem Therapeutic Inc., as a result of an amalgamation, corporations governed by the Canada Business Corporations Act The Canada Business Corporations Act, also known as Bill C-44, is a Canadian act respecting Canadian business corporations. See also
This change will have no effect whatsoever on the assets, liabilities, management, business or financial conditions of BioChem Pharma other than a change in its corporate governing law. The purpose of the change is to render uniform the governance of all Canadian companies of BioChem Pharma. BioChem Pharma is an international biopharmaceutical company dedicated to the research, development and commercialization of innovative products for the prevention, detection, and treatment of human diseases. The Company's shares are traded on the Montreal and Toronto Stock Exchanges (BCH) and on NASDAQ National Market (BCHE). CONTACT: Christine Lennon / Michele Roy BioChem Pharma Inc. (514) 978-7771 E-mail: corpcom@biochem-pharma.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion